Model for projecting COVID-19 hospital and ICU admissions, complete with code RIVM has published the code for model projections of COVID-19 hospital and ICU admissions. The code has been shared as part of a manuscript about the model.
MEBI: 193 reports of suspected side effects of implants in 2022 In 2022, 193 individuals reported suspected side effects of implants to RIVM’s Dutch Reporting Centre for Adverse Effects of Medical Implants (MEBI). Most reports received concerned breast implants, copper IUDs and wrinkle fillers. This is highlighted in MEBI’s annual report.
RIVM publishes new data from manufacturers on tobacco products On behalf of the Dutch Ministry of VWS (Health, Welfare and Sport), RIVM has published new data on tobacco products. For the first time, these data include the ingredients of e-cigarettes, heated tobacco products and herbal smoking products.
GPs feel more personalised care for chronically ill patients was useful during coronavirus pandemic During the coronavirus pandemic, GPs had to take over some of the tasks of hospitals and mental healthcare providers.
From 1 October 2023, heel prick test also screens for metabolic disorder ALD From 1 October 2023, the blood of newborn babies will also be tested for the metabolic disorder adrenoleukodystrophy (ALD). This is done with the heel prick screening test.
Darker cigarettes and other measures to make cigarettes less appealing There are a number of measures that can be implemented to make cigarettes less appealing and less addictive. For example, manufacturers could make cigarettes a darker colour. They could also stop using ingredients like sugars and flavourings.
RIVM prepares a recommended list of banned substances in tobacco products and e-cigarettes The goal of the European Tobacco Products Directive is to make tobacco products and e-cigarettes less harmful, addictive and attractive. The directive does not specifically state which substances are not allowed in tobacco products and e-cigarettes.
Post-COVID less common after Omicron infection After a SARS-CoV-2 infection involving Omicron, 1 in 10 people still have symptoms three months later. This is almost 2 times lower than after an infection involving the Delta variant. This is evident from new results of the LongCOVID study at RIVM. There is variation in the frequency of specific post-COVID symptoms after an infection with the Omicron or Delta variant.
Number of tuberculosis patients in the Netherlands decreased slightly in 2022 compared to 2021 The number of people with tuberculosis (TB) in the Netherlands decreased slightly in 2022. In 2022, there were 635 TB patients in the Netherlands. This is six per cent fewer than in 2021, when there were 673 patients.
NIPT available as standard option for all pregnant women from 1 April From 1 April 2023, the Non-Invasive Prenatal Test (NIPT) will be available to all pregnant women. They do not have to take part in a scientific study for this.